Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival

To evaluate tumor blood flow using (15)O-water positron emission tomography (PET) in patients with non-small cell lung cancer (NSCLC) before and after chemotherapy with bevacizumab, and to investigate the effects of bevacizumab on tumor blood flow changes and progression-free survival (PFS). Twelve...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Daisuke, Yanagawa, Masahiro, Matsunaga, Keiko, Watabe, Hiroshi, Watabe, Tadashi, Kato, Hiroki, Kijima, Takashi, Takeda, Yoshito, Kumanogoh, Atsushi, Shimosegawa, Eku, Hatazawa, Jun, Tomiyama, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991665/
https://www.ncbi.nlm.nih.gov/pubmed/33762653
http://dx.doi.org/10.1038/s41598-021-86405-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991665/
https://www.ncbi.nlm.nih.gov/pubmed/33762653
http://dx.doi.org/10.1038/s41598-021-86405-w

Ejemplares similares